Filter
2441
Text search:
drug
adherence
Featured
Recommendations
238
New Publications
670
Language
Document type
No document type
1546
Guidelines
339
Studies & Reports
303
Manuals
97
Strategic & Response Plan
72
Training Material
32
Fact sheets
30
Situation Updates
8
Infographics
6
Resource Platforms
5
Brochures
1
Countries / Regions
India
148
Kenya
101
South Africa
77
Uganda
65
Tanzania
65
Ethiopia
63
Global
63
Western and Central Europe
61
Zambia
49
Malawi
48
Nigeria
46
Ghana
39
Namibia
36
Nepal
33
Latin America and the Carribbean
33
Eastern Europe
33
Africa
32
Sierra Leone
31
Liberia
31
Rwanda
28
Myanmar / Burma
26
Lesotho
24
Zimbabwe
23
Asia
19
Ukraine
18
Botswana
18
Cambodia
17
Bangladesh
17
Russia
14
Philippines
13
South–East Asia Region
13
Mozambique
11
East and Southern Africa
10
Eswatini/ Swaziland
9
Indonesia
7
Brazil
7
West and Central Africa
7
Georgia
7
USA
6
Syria
6
Senegal
5
Congo, Democratic Republic of
5
Thailand
5
Eastern Europe and Central Asia
5
Albania
5
Burkina Faso
4
Pakistan
4
China
4
Sudan
4
Sri Lanka
4
Chile
4
Armenia
4
Vietnam
4
Guinea
3
Cameroon
3
Haiti
3
South Sudan
3
Jordan
3
Afghanistan
3
Germany
3
Benin
3
Western Pacific Region
3
Bhutan
3
Timor Leste/ East Timor
3
North America
3
Jamaica
3
United Kingdom
3
Argentina
2
North Macedonia
2
Colombia
2
Middle East and North Africa
2
Laos
2
Tajikistan
2
Estonia
2
Saudi Arabia
1
Somalia
1
Lebanon
1
Turkey
1
Gambia
1
Singapore
1
Central African Republic
1
Hungary
1
El Salvador
1
Angola
1
Paraguay
1
Poland
1
North Korea
1
Southern Africa
1
Canada
1
Qatar
1
Romania
1
Moldova
1
Denmark
1
Belgium
1
France
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
955
Clinical Guidelines
232
Public Health
119
Women & Child Health
74
Key Resources
51
Capacity Building
50
Pharmacy & Technologies
24
Toolboxes
HIV
471
TB
362
Mental Health
156
AMR
89
NCDs
77
COVID-19
64
Pharmacy
63
NTDs
56
Caregiver
43
Malaria
42
Refugee
22
Rapid Response
21
Ebola & Marburg
20
Conflict
16
Polio
12
Global Health Education
11
2.0 Rapid Response
11
Disability
10
Planetary Health
8
Natural Hazards
5
Cholera
4
Social Ethics
4
Health Financing Toolbox
4
Specific Hazards
3
Zika
2
International Journal of Drug Policy 24 (2013) e91-98
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver remi
...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in distric
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequ
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation w
...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with
...
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
